La prise en compte des femmes dans les essais cliniques : il serait temps de transformer l’essai ! (notice n° 1615433)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03471cam a2200349 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260111073246.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Charreire Petit |
| Fuller form of name | <br/> (D)<br/> |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | La prise en compte des femmes dans les essais cliniques : il serait temps de transformer l’essai ! |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2025.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 72 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Notre article vise à mieux comprendre et qualifier l’impact de la sous-représentation des femmes dans les essais cliniques sur les innovations en santé. La prise en compte des femmes dans les essais cliniques a fait l’objet d’un certain nombre de recherches, en médecine, mais aussi en sciences de gestion. Cependant, aucune étude n’a mené d’analyse longitudinale à l’échelle internationale sur la présence des femmes dans les essais cliniques. Fondée sur une base de données recensant de façon exhaustive les essais cliniques publiés sur le site Clinicaltrials, notre recherche montre une inclusion grandissante des femmes dans les essais cliniques (avec une exception pour la phase 1). Cependant, très peu d’essais cliniques distinguent les résultats par genre, et encore moins s’intéressent explicitement aux effets différenciés des traitements en fonction du genre. Ce résultat en trompe-l’œil représente donc une progression inachevée car les différences biologiques et sociales potentielles entre femmes et hommes restent invisibilisées. Nous montrons en quoi l’intégration en pratique du genre, dès l’idéation, dans le processus d’innovation en santé, permettrait de contribuer à l’amélioration de la santé des femmes. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This article aims to better understand and assess the impact of women’s underrepresentation in clinical trials on health innovations. The inclusion of women in clinical trials has been the subject of several studies, both in medicine and in management sciences. However, no research to date has conducted a longitudinal international analysis of women’s participation in clinical trials. Based on a comprehensive database of clinical trials published on the ClinicalTrials website, our study shows a growing inclusion of women in clinical trials (with the exception of Phase 1 trials). However, very few trials report results by gender, and even fewer explicitly examine differential treatment effects according to gender. This misleading progress therefore represents an unfinished achievement, as potential biological and social differences between women and men remain largely invisible. We show how the practical integration of gender considerations – beginning at the ideation stage – within the health innovation process could contribute to improving women’s health outcomes. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Analyse longitudinale |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Design thinking |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Essais cliniques |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Genre |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Idéation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | invisibilisation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Androcentrime. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Androcentrism |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Clinical trials |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Design thinking |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Gender |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Ideation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Invisibilization |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Longitudinal analysis |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Coron, Clotilde |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Journal de gestion et d'économie de la santé | 2 | 2 | 2025-12-09 | p. 65-82 | 2262-5305 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-journal-de-gestion-et-deconomie-de-la-sante-2025-2-page-65?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-journal-de-gestion-et-deconomie-de-la-sante-2025-2-page-65?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux